Professional Research Publications
Analysis of Individual Items on the Attention-Deficit/Hyperactivity Disorder Symptom Rating Scale in Children and Adults: Part 1. The Effects of Age and Sex in Pivotal Trials of Lisdexamfetamine Dimesylate.
Weisler R, Adler LA, Kollins SH, Goodman DW, Hamdani M, Dirks B, Childress A. Analysis of Individual Items on the Attention-Deficit/Hyperactivity Disorder Symptom Rating Scale in Children and Adults: Part 1. The Effects of Age and Sex in Pivotal Trials of Lisdexamfetamine Dimesylate. J of Atten Disorders (in press)
Response and Symptomatic Remission in Short- and Long-Term Trials of Lisdexamfetamine Dimesylate in Adults with Attention Deficit/Hyperactivity Disorder.
Mattingly GW, Weisler RH, Young J, Dirks B, Babcock T, Lasser R, Scheckner B, Goodman DW. Response and Symptomatic Remission in Short- and Long-Term Trials of Lisdexamfetamine Dimesylate in Adults with Attention Deficit/Hyperactivity Disorder. J of Clin Psychiatry (in press)
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults: A Fresh Appraisal. Advances in Psychiatric Medicine
Goodman DW and Robb AS. Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults: A Fresh Appraisal. Advances in Psychiatric Medicine (suppl to Psychiatric Times) May 2010. CME accredited.
Moderators and Mediators of Symptoms and Quality of Life Outcomes in an Open-Label Study of Adults Treated for Attention-Deficit Hyperactivity Disorder
Weiss MD, Gibbins C, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV. Moderators and Mediators of Symptoms and Quality of Life Outcomes in an Open-Label Study of Adults Treated for Attention-Deficit Hyperactivity Disorder. J of Clin Psych. April 2010:71(4):381-390 [button size=’large’ color=’btn-b76lpc214h’ link=’https://addadultdev2024.talondigital.com/wp-content/uploads/2014/01/Weiss_M_et_al._2010_Moderators_and_Mediators_of_Symptoms_adn_QOL_in_Adult_ADHD.pdf’ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]
Interpreting ADHD Rating Scale Scores: Linking ADHD Rating Scale Scores and CGI Levels in Two Randomized Controlled Trials of Lisdexamfetamine Dimesylate in ADHD
Goodman DW, Faraone SV, Adler LA, Dirks B, Hamdani M, Weisler R. Interpreting ADHD Rating Scale Scores: Linking ADHD Rating Scale Scores and CGI Levels in Two Randomized Controlled Trials of Lisdexamfetamine Dimesylate in ADHD. Primary Psychiatry. March 2010; 17(3)38-46 [button size=’large’ color=’btn-b76lpc214h’ link=’https://addadultdev2024.talondigital.com/wp-content/uploads/2010/03/Goodman-DW-et-al-2010-Interpreting-ADHD-Rating-Scale-Scores-Linking-ADHD-RS-to-CGI-in-Two-LDX-Trials.pdf’ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]
A Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder
Goodman DW. Lisdexamfetamine Dimesylate (Vyvanse), a Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder. Pharmacy and Therapeutics. May 2010;35(5):273-287
ADHD in Adults: Update for Clinicians on Diagnosis and Assessment.
David W. Goodman, M.D. ADHD in Adults: Update for Clinicians on Diagnosis and Assessment. First published in Psychiatry Weekly, Volume 4, Issue 27, on November 30, 2009 [button size=’large’ color=’btn-b76lpc214h’ link=’https://www.psychiatryweekly.com/aspx/Article/articledetail.aspx?articleid=1037′ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]
Recognizing ADHD in Adults with Comorbid Mood Disorders: Implications for Identification and Management.
David W. Goodman, MD, Michael E. Thase, MD. Recognizing ADHD in Adults with Comorbid Mood Disorders: Implications for Identification and Management. © Postgraduate Medicine, Volume 121, Issue 5, September 2009, ISSN – 0032-5481, e-ISSN – 1941-9260 [button size=’large’ color=’btn-b76lpc214h’ link=’https://addadultdev2024.talondigital.com/wp-content/uploads/2014/01/Goodman-Thase-2009.pdf’ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]
Expert Panel Supplement Differential Diagnosis Of Adult Attention-Deficit/Hyperactivity Disorder
David Goodman, MD, Roger McIntyre, MD, FRCPC, Oscar Bukstein, MD, MPH. Expert Panel Supplement Differential Diagnosis Of Adult Attention-Deficit/Hyperactivity Disorder: Treatment Options And Comorbidity Considerations. CNS Spectrums – July 2009. Expert Panel Supplement [button size=’large’ color=’btn-b76lpc214h’ link=’https://addadultdev2024.talondigital.com/wp-content/uploads/2014/01/Goodman-D-2009-Diff-Dx-ADHD-Tx-Options-and-Comorbidity.pdf’ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]
Dose Response Effects of Lisdexamfetamine Dimesylate Treatment in Adults With ADHD: An Exploratory Study
Stephen V. Faraone, Thomas J. Spencer, Scott H. Kollins, Stephen J. Glatt and David Goodman. Dose Response Effects of Lisdexamfetamine Dimesylate Treatment in Adults With ADHD: An Exploratory Study. Journal of Attention Disorders published online April 28, 2011 [button size=’large’ color=’btn-b76lpc214h’ link=’https://addadultdev2024.talondigital.com/wp-content/uploads/2011/04/Faraone_SV_et_al_2011_Dose_Response_Effects_of_LDX_Tx_in_Adults_with_ADHD_An_Explortory_Study.pdf’ align=’center’ block=’0′ icon=’FontAwesome/fontawesome-chevron-sign-right||color:ffffff’ shadow=’2′]Read Full Article[/button]